Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Braicu · SciRah

Researcher profile · Semantic Scholar

I. Braicu

Share profile

I. Braicu — researcher profile on SciRah

h-index: 29
Works: 120
Citations: 2,741

Most-cited papers

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
S. Darb-Esfahani, C. Kunze, H. Kulbe, J. Sehouli +8 more
2015OncoTarget252 citations Open access
Semantic Scholar
GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis
O. Cabral-Marques, A. Marques, L. Giil, R. De Vito +32 more
2018Nature Communications168 citations Open access
Semantic Scholar
The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study.
G. Hofstetter, N. Concin, I. Braicu, R. Chekerov +11 more
2013Gynecologic Oncology129 citations
Semantic Scholar
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.
E. Obermayr, D. Castillo-Tong, Dietmar Pils, P. Speiser +6 more
2013Gynecologic Oncology127 citations
Semantic Scholar
Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data
S. Polterauer, I. Vergote, N. Concin, I. Braicu +8 more
2012International Journal of Gynecologic Cancer108 citations Open access
Semantic Scholar
Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium
Dietmar Pils, G. Hager, D. Tong, S. Aust +12 more
2012Cancer Science75 citations Open access
Semantic Scholar
Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation
C. Fotopoulou, R. Zang, M. Gultekin, D. Cibula +13 more
2013Annals of Surgical Oncology74 citations
Semantic Scholar
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
Dietmar Pils, Anna Bachmayr-Heyda, K. Auer, M. Svoboda +14 more
2014European Journal of Cancer71 citations
Semantic Scholar
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
J. Patel, I. Braicu, K. Timms, C. Solimeno +7 more
2018British Journal of Cancer64 citations Open access
Semantic Scholar
MALDI‐Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods
Oliver Klein, Frederic Kanter, H. Kulbe, P. Jank +11 more
2018PROTEOMICS - Clinical Applications64 citations Open access
Semantic Scholar
Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration
C. Mayer, S. Darb-Esfahani, A. Meyer, K. Hübner +6 more
2016Journal of Cancer58 citations Open access
Semantic Scholar
tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression
Konstantina Panoutsopoulou, T. Dreyer, J. Dorn, E. Obermayr +7 more
2021Cancers52 citations Open access
Semantic Scholar
Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD
R. Chekerov, I. Braicu, D. Castillo-Tong, R. Richter +9 more
2012International Journal of Gynecologic Cancer51 citations Open access
Semantic Scholar
Association of myeloperoxidase with ovarian cancer
D. Castillo-Tong, Dietmar Pils, G. Heinze, I. Braicu +8 more
2013Tumor Biology49 citations Open access
Semantic Scholar
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
F. Trillsch, L. Woelber, C. Eulenburg, I. Braicu +11 more
2013Journal of Ovarian Research49 citations Open access
Semantic Scholar
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma.
E. Taube, C. Denkert, J. Sehouli, C. Kunze +4 more
2016Gynecologic Oncology47 citations
Semantic Scholar
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.
E. Despierre, M. Moisse, B. T. Yesilyurt, J. Sehouli +10 more
2014Gynecologic Oncology47 citations
Semantic Scholar
Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer
P. Kordowitzki, B. Lange, Kevin M Elias, Marcia C. Haigis +3 more
2025Ca46 citations Open access
Semantic Scholar
p53 and p16 expression profiles in vulvar cancer - a translational analysis by the AGO-CaRE- study group.
L. Woelber, K. Prieske, C. Eulenburg, L. Oliveira-Ferrer +22 more
2021American Journal of Obstetrics and Gynecology40 citations Open access
Semantic Scholar
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
Dietmar Pils, D. Tong, G. Hager, E. Obermayr +13 more
2013BMC Cancer38 citations Open access
Semantic Scholar
Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors.
Anastasia Lazarou, C. Fotopoulou, A. Coumbos, J. Sehouli +4 more
2014Anticancer Research35 citations
Semantic Scholar
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
K. Miller, J. Patel, Qing Zhang, E. J. Norris +12 more
2018Gynecologic Oncology34 citations
Semantic Scholar
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer
F. Marmé, T. Hielscher, S. Hug, Sandra Bondong +12 more
2012International Journal of Cancer34 citations
Semantic Scholar
A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.
I. Vasconcelos, J. Olschewski, I. Braicu, J. Sehouli
2015The Oncologist31 citations Open access
Semantic Scholar
Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma
A. Okamoto, J. Sehouli, N. Yanaihara, Y. Hirata +22 more
2015PLoS ONE30 citations Open access
Semantic Scholar
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
Mandy Stanske, S. Wienert, D. Castillo-Tong, C. Kreuzinger +15 more
2018Neoplasia29 citations Open access
Semantic Scholar
ERCC1 expression as a predictor of resistance to platinum-based chemotherapy in primary ovarian cancer.
M. Muallem, I. Braicu, M. Nassir, R. Richter +2 more
2014Anticancer Research29 citations
Semantic Scholar
Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?
C. Fotopoulou, Konstantinos Savvatis, P. Kosian, I. Braicu +4 more
2013British Journal of Cancer28 citations Open access
Semantic Scholar
Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
C. Fotopoulou, I. Braicu, J. Sehouli
2012Obstetrics and Gynecology International28 citations Open access
Semantic Scholar
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
I. Ray-Coquard, I. Braicu, R. Berger, S. Mahner +10 more
2019Frontiers in Oncology25 citations Open access
Semantic Scholar
tRNA-derived small RNA 3'U-tRFValCAC promotes tumour migration and early progression in ovarian cancer.
Konstantina Panoutsopoulou, Paraskevi Magkou, T. Dreyer, J. Dorn +8 more
2022European Journal of Cancer23 citations
Semantic Scholar
Interferon-stimulated Gene, 15 kDa (ISG15) in Ovarian High-grade Serous Carcinoma: Prognostic Impact and Link to NF-&kgr;B Pathway
S. Darb-Esfahani, B. Sinn, Marc Rudl, J. Sehouli +3 more
2014International Journal of Gynecological Pathology23 citations
Semantic Scholar
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology
N. Pfarr, S. Darb-Esfahani, J. Leichsenring, E. Taube +10 more
2017Genes, Chromosomes and Cancer22 citations
Semantic Scholar
PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors.
P. Lohneis, S. Darb-Esfahani, M. Dietel, I. Braicu +2 more
2015Anticancer Research22 citations
Semantic Scholar
Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
A. Seeber, I. Braicu, G. Untergasser, M. Nassir +7 more
2015OncoTarget22 citations Open access
Semantic Scholar
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns
Ivana Türbachova, T. Schwachula, I. Vasconcelos, A. Mustea +31 more
2013Epigenetics22 citations Open access
Semantic Scholar
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium.
A. Melmer, L. Fineder, C. Lamina, B. Kollerits +11 more
2013Gynecologic Oncology21 citations
Semantic Scholar
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
J. Gostner, E. Obermayr, I. Braicu, N. Concin +6 more
2018Gynecologic Oncology20 citations Open access
Semantic Scholar
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study
D. Phelps, J. Borley, K. Flower, R. Dina +13 more
2017British Journal of Cancer19 citations Open access
Semantic Scholar
Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors.
I. Vasconcelos, J. Olschewski, I. Braicu, J. Sehouli
2015European Journal of Obstetrics, Gynecology, and Reproductive Biology18 citations
Semantic Scholar
Duration of storage influences the hemoglobin rising effect of red blood cells in patients undergoing major abdominal surgery
O. Hunsicker, Katarina Hessler, A. Krannich, W. Boemke +6 more
2018Transfusion17 citations
Semantic Scholar
Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
S. Aust, K. Auer, Anna Bachmayr-Heyda, C. Denkert +10 more
2014Molecular Cancer17 citations Open access
Semantic Scholar
Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)
A. Mustea, D. Koensgen, A. Belau, J. Sehouli +10 more
2013Cancer Chemotherapy and Pharmacology17 citations
Semantic Scholar
AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer
M. Svoboda, A. Meshcheryakova, G. Heinze, M. Jaritz +14 more
2016BMC Genomics16 citations Open access
Semantic Scholar
Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells
H. Kulbe, F. Iorio, P. Chakravarty, C. Milagre +11 more
2016OncoTarget16 citations Open access
Semantic Scholar
Transfusion of red blood cells does not impact progression‐free and overall survival after surgery for ovarian cancer
O. Hunsicker, Sara Gericke, J. Graw, A. Krannich +7 more
2019Transfusion15 citations Open access
Semantic Scholar
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, M. Dragomir, Nanna Monjé, Carlotta Keunecke +15 more
2023Neoplasia13 citations Open access
Semantic Scholar
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
Konstantina Panoutsopoulou, M. Avgeris, K. Mavridis, T. Dreyer +12 more
2020Carcinogenesis12 citations Open access
Semantic Scholar
miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients
Konstantina Panoutsopoulou, M. Avgeris, Paraskevi Magkou, K. Mavridis +13 more
2020International Journal of Cancer11 citations Open access
Semantic Scholar
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network
D. Koensgen, M. Stope, Ivana Tuerbachova, D. Bruennert +9 more
2017Gynecologic and Obstetric Investigation11 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Sehouli×42
Invite
J. Sehouli — researcher profile on SciRah
S. Mahner×22
Invite
S. Mahner — researcher profile on SciRah
R. Zeillinger×19
Invite
R. Zeillinger — researcher profile on SciRah
I. Vergote×18
Invite
I. Vergote — researcher profile on SciRah

S. Darb-Esfahani

×12

Invite

S. Darb-Esfahani — researcher profile on SciRah

D. Castillo-Tong×11

Invite

D. Castillo-Tong — researcher profile on SciRah

Invite

C. Denkert — researcher profile on SciRah

Invite

E. Obermayr — researcher profile on SciRah

Invite

T. van Gorp — researcher profile on SciRah

Dietmar Pils×7

Invite

Dietmar Pils — researcher profile on SciRah

Invite

N. Concin — researcher profile on SciRah

Invite

P. Speiser — researcher profile on SciRah